NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global endoscopic closure devices market size is estimated to grow by USD 825.7 million from 2025-2029, ...

CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...

BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...

Able Medical’s sternal closure system utilizes PEEK (polyether ether ketone) to provide surgeons with a strong, lightweight ...

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...

BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...

SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...

The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24. The new add-on CPT code ...